Director, Key Account Management
Company Overview:
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
The Director, Key Account Management (KAM) is the primary commercial liaison between Beam Therapeutics and its network of Authorized Treatment Centers (ATCs). The KAM is accountable for end-to-end account performance — from site qualification and onboarding through sustained therapy utilization — and serves as the field-based lead of the cross-functional pod (Medical Affairs
